Sptbn2 gene associated with spinocerebellar ataxia type 5 and methods of use
CA 2598281 C · Owner: Dick, Katherine A. · Inventors: Schut, Lawrence J.; Day, John W.; Ranum, Laura P. W.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention provides methods that include analyzing an SPTBN2 polynucleotide, and determining whether the SPTBN2 polynucleotide includes a mutation. , The methods may be used to identify a subject that is at risk or not at risk for developing , spinocerebellar ataxia type 5. The present invention also provides isolated polynucleotides , having a mutation present in an SPTBN2 polynucleotide.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed February 22, 2006 and granted August 9, 2016. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended February 22, 2026.
- Certificates of supplementary protection extend only drug patents, and it isn't classified as one.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.